chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: M
Vaccine: COVID19
Symptoms: Immunisation reaction
Clinical narrative: RESIDUAL EFFECTS; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (dose in series 1) (suspension for injection, intramuscular, batch number was not reported) dose, start therapy date were not reported for covid-19 prophylaxis. The batch number was not reported. we are unable to perform follow up to request batch/lot numbers .No concomitant medications were reported. On an unspecified date, the patient experienced residual effects (dose in series 1). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of residual effects was not reported. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Hospitalisation
Clinical narrative: HOSPITAL ADMISSION; This spontaneous report received from a patient via J and J managed social media concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (dose series 1) (suspension for injection, intramuscular, batch number was not reported) dose was not reported, administered on 15-MAY-2021 for covid-19 prophylaxis. The batch number was not reported. We are unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On 30-MAY-2021, the patient experienced hospital admission (dose series 1), and was hospitalized. The patient reported that the patient got J&J Covid vaccine on 15-MAY-2021 and by 30-MAY-2021 was in ICU, so the patient too could have a pulmonary embolism. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of hospital admission was not reported. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0:  Hospitalisation: The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event than the drug. Specifically: NATURE OF EVENT. Therefore, this event is considered not related.
Sex: F
Vaccine: COVID19
Symptoms: Suspected COVID-19
Clinical narrative: SUSPECTED COVID-19; This spontaneous report received from a consumer and concerned a female patient of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (dose series 1) (suspension for injection, intramuscular, batch number was not reported) dose, start therapy date were not reported for covid-19 prophylaxis. Batch number was not provided and have been requested. No concomitant medications were reported. On an unspecified date, the patient experienced suspected covid-19 (dose series 1). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of suspected covid-19 was not reported. This report was non-serious. This case, from the same reporter is linked to 20240527839.
Sex: F
Vaccine: COVID19
Symptoms: Immunisation reaction
Clinical narrative: LIFE EXTREMELY DIFFICULT; This spontaneous report received from a consumer concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s(dose in series 1) (suspension for injection, intramuscular, batch number was not reported) dose, start therapy date were not reported for covid-19 prophylaxis. The batch number was not reported. we are unable to perform follow up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient experienced life extremely difficult (dose in series 1). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of life extremely difficult was not reported. This report was non-serious. This case, from the same reporter is linked to 20240808424.
Sex: U
Vaccine: COVID19
Symptoms: Hypersensitivity
Clinical narrative: severe reaction; This is a spontaneous report received from a Consumer or other non HCP.  A patient (age and gender not provided) received BNT162b2 (BNT162B2 NOS), in 2023 as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HYPERSENSITIVITY (medically significant), outcome "unknown", described as "severe reaction". Clinical course: Patient had a severe reaction from last Pfizer covid vaccine last fall It was given at the (withheld) in (withheld city, state).  The information on the batch/lot number for BNT162b2 will be requested and submitted if and when received.
Age: 57.0
Sex: F
Vaccine: TD
Symptoms: Expired product administered, No adverse event
Clinical narrative: patient received the expired vaccine (with no reported adverse event); Initial information received on 08-Aug-2024 regarding an unsolicited valid non-serious case received via nurse.  This case is linked with several case Ids.  This case involves a 57-year-old female patient received the expired diphtheria-2/tetanus-5 adsorbed toxoids no preservative adult [Tenivac] (with no reported adverse event).  The patient's past medical history, medical treatment(s), vaccination(s), concomitant(s) and family history were not provided.   On 11-Dec-2023, the patient received a 0.5 ml dose of suspect diphtheria-2/tetanus-5 adsorbed toxoids no preservative adult, Suspension for injection (strength: unknown) (lot: U7183AA, expiry date: 24-Sep-2024) via intramuscular route in unknown administration site as immunization and patient received the expired vaccine (with no reported adverse event) (expired product administered) (latency: same day).  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 4.0
Sex: M
Vaccine: HIBV
Symptoms: No adverse event, Product preparation error
Clinical narrative: ACTHIB that was mixed with a wrong diluent and was given to the patient (with no reported adverse event); ACTHIB that was mixed with a wrong diluent and was given to the patient (with no reported adverse event); Initial information received on 07-Aug-2024 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a 4 years old male patient to whom HIB (PRP/T) Vaccine [ACT-HIB] that was mixed with a wrong diluent and was given to the patient (with no reported adverse event).  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included Hepatitis A Vaccine (Hepatitis A), Measles Vaccine, Mumps Vaccine, Rubella Vaccine (Measles Vaccine;Mumps Vaccine;Rubella Vaccine) And And Varicella Zoster Vaccine (Varicella Vaccine) for Immunisation.  On 26-Jun-2024, the patient received HIB (PRP/T) Vaccine dose 0.5 ml TOTAL, Powder and solvent for solution for injection lot UJ977AA via intramuscular route in the right deltoid for Immunization (strength, expiry date unknown) that was mixed with a wrong diluent and was given to the patient (with no reported adverse event) (product preparation error) (poor quality product administered) (latency same day).   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 12.0
Sex: F
Vaccine: HIBV, VARCEL
Symptoms: Granuloma
Clinical narrative: Vaccine granuloma
Age: 0.42
Sex: F
Vaccine: DTAPIPVHIB, PNC20
Symptoms: Mouth swelling
Clinical narrative: The patients mother states that when she went to give the milk, noted that under the tongue was swollen.
Age: 1.0
Sex: F
Vaccine: HEPA, MMRV, PNC20, VARCEL
Symptoms: Wrong product administered
Clinical narrative: Patient was administered the incorrect vaccine. Our patient received MMRV instead of the intended vaccine, MMR.
Age: 51.0
Sex: M
Vaccine: PNC20, VARZOS
Symptoms: No adverse event, Wrong product administered
Clinical narrative: Member received pneumonia vaccine instead of ordered meningococcal. At subsequent visit to ID physician, it was discovered that the pneumonia vaccine was needed. no adverse reactions from administered pneumonia vaccine.
Age: 11.0
Sex: M
Vaccine: DTAP, HPV9, MNQ, VARCEL, HPV9, MNQ, RAB, TDAP
Symptoms: Rash, Rash erythematous, Rash papular, Rash pustular
Clinical narrative: My son came from practice, he had taken off his shirt so I could do the laundry, and he had what looked like a red raised area about two quarters beside each other on the back of his right arm. Then on his chest, his nose, and his back, he had raised red bumps. The one on his nose look like it had puss in it. After giving him benadryl it went down really quick. I checked on him at like 3 am and everything was down and not raised anymore.
Age: 11.0
Sex: M
Vaccine: DTAP, HPV9, MNQ, VARCEL, HPV9, MNQ, RAB, TDAP
Symptoms: Rash
Clinical narrative: My son came from practice, he had taken off his shirt so I could do the laundry, and he had what looked like a red raised area about two quarters beside each other on the back of his right arm. Then on his chest, his nose, and his back, he had raised red bumps. The one on his nose look like it had puss in it. After giving him benadryl it went down really quick. I checked on him at like 3 am and everything was down and not raised anymore.
Age: 11.0
Sex: M
Vaccine: DTAP, HPV9, MNQ, VARCEL, HPV9, MNQ, RAB, TDAP
Symptoms: Rash, Rash erythematous, Rash papular, Rash pustular
Clinical narrative: According to client's mother: "last night (08/12/2024 about 9 pm) when he was removing his shirt we noted a rash at front/backof torso, both arms and face. We called Poison Control and Vaccine Adverse Event Reporting System. We gave him benadryl and applied hydrocortisone cream".
Age: 11.0
Sex: M
Vaccine: DTAP, HPV9, MNQ, VARCEL, HPV9, MNQ, RAB, TDAP
Symptoms: Rash
Clinical narrative: According to client's mother: "last night (08/12/2024 about 9 pm) when he was removing his shirt we noted a rash at front/backof torso, both arms and face. We called Poison Control and Vaccine Adverse Event Reporting System. We gave him benadryl and applied hydrocortisone cream".
Age: 12.0
Sex: M
Vaccine: HPV9
Symptoms: Immediate post-injection reaction, Syncope
Clinical narrative: Immediately after injection patient fainted.
Age: 14.0
Sex: F
Vaccine: HEPA, IPV, MNQ, TDAP, VARCEL
Symptoms: Confusional state, Fatigue, Posture abnormal, Syncope, Tonic clonic movements
Clinical narrative: The patient arrived at the clinic seeking vaccines for public school admission. Upon reviewing the record, the above vaccines were needed. The parent and patient were explained the total amount of required vaccines and were given VIS forms. Vaccines were prepared and all vaccines were administered to the right arm. Upon administering the varicella vaccine to her left arm, the patient experienced a syncope episode and her head fell on the phlebotomy chair's padded armrest. The patient experienced tonic-clonic-like movements for approximately 30 seconds and then responded completely looking tired and confused.
Age: 57.0
Sex: M
Vaccine: TD
Symptoms: Injection site nodule, Injection site pain, Injection site paraesthesia, Injection site pruritus, Injection site warmth
Clinical narrative: Patient came in on 8/12/2024 with concerns about a vaccine that was received on 8/5/2024.  Patient reports that the day after the vaccine (Wednesday) his arm was swollen and he had a 'knot' in the area the shot was administered. Patient stated the swelling is finally decreasing from last week, it still seemed a bit swollen compared to his other arm.  On Thursday (8/8/2024) patient stated that his arm itched. The area he referred to was between the lower bicep and above the elbow. Not near the injection site.  Patient states that cold compersses have helped, but still feels warmthing, but a little tingling and burning in the arm (localized to the area that is currently itching).  I notified patient that his symptoms were what sounded like a localized reaction. I notified him that from what he was describing it sounded that his symptoms were improving. I told him it could take at least a week for symptoms to go away.  We discussed signs of anaphylaxsis and if his symptoms become worse to notify his prescriber. I recommended to continue ice compressions, benadryl, and hydrocortisone cream.  As I review when the patient received the vaccination, the dates he provided 8/5 does not match up with when he received the vaccine 8/7
Age: 57.0
Sex: M
Vaccine: TD
Symptoms: Peripheral swelling
Clinical narrative: Patient came in on 8/12/2024 with concerns about a vaccine that was received on 8/5/2024.  Patient reports that the day after the vaccine (Wednesday) his arm was swollen and he had a 'knot' in the area the shot was administered. Patient stated the swelling is finally decreasing from last week, it still seemed a bit swollen compared to his other arm.  On Thursday (8/8/2024) patient stated that his arm itched. The area he referred to was between the lower bicep and above the elbow. Not near the injection site.  Patient states that cold compersses have helped, but still feels warmthing, but a little tingling and burning in the arm (localized to the area that is currently itching).  I notified patient that his symptoms were what sounded like a localized reaction. I notified him that from what he was describing it sounded that his symptoms were improving. I told him it could take at least a week for symptoms to go away.  We discussed signs of anaphylaxsis and if his symptoms become worse to notify his prescriber. I recommended to continue ice compressions, benadryl, and hydrocortisone cream.  As I review when the patient received the vaccination, the dates he provided 8/5 does not match up with when he received the vaccine 8/7
Age: 11.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Blood pressure decreased, Head injury, Heart rate decreased, Syncope
Clinical narrative: pt had syncopal episode 5 minutes after shots administered. pt hit head on floor, ice applied, VS assessed. neuros intact immediately, MD at bedside.  Ambulance called for low BP/HR.
Age: 70.0
Sex: M
Vaccine: PNC20, RSV
Symptoms: Dermatitis, Rash, Rash erythematous
Clinical narrative: Starting approximately 2 days post vaccination patient developed a widespread diffuse rash over a large portion of his body.  He indicated the rash is present under arms, on torso, and down the legs. He described the rash as red, inflamed, and non-itchy.
Age: 3.0
Sex: M
Vaccine: DTAPHEPBIP, HEPA, VARCEL
Symptoms: Injection site rash, Rash, Rash erythematous, Rash pruritic, Varicella post vaccine
Clinical narrative: The Varivax was given on 29-JUL-2024 and a rash developed at the site of vaccination on 10-AUG-2024 that appeared to be insect bites. The rash spread to the face, arms, and the legs the next day, however, the patient's guardian stated the rash is pruritic and appears to be small white bumps on a red base. Patient's guardian denied patient having any fever or other symptoms. Advised guardian to give patient diphenhydramine orally and use calamine lotion topically to help with itching. Most likely a mild case of Varicella infection with vaccine strain.
Sex: F
Vaccine: UNK, UNK, UNK, UNK
Symptoms: No adverse event, Single component of a two-component product administered
Clinical narrative: There was no adverse reaction.  Issue was Hib was not reconstituted with accompying saline diluent
Age: 18.0
Sex: F
Vaccine: MENB
Symptoms: Injection site pain, Pain
Clinical narrative: MOP presents to Immunizations clinic and reports pt is having severe pain at vaccine sight that radiates to her back. Symptoms started approximately 2 hours after vaccination. Pt has taken Ibuprofen and Tylenol since and has had little relief.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Palpitations, Tremor
Clinical narrative: Woke on 4/16/21 with shakiness to her legs, chills, and pounding heart. Per drs appt on 4/19/21, seemed to self resolve the following day. Still having intermittent palpitations- 1-2x per day with about 5 beats of pounding heart then back to normal. Referred to cardiologist for follow up on palpitations. No further information available.
Age: 38.0
Sex: F
Vaccine: MMRV, VARCEL
Symptoms: Extra dose administered
Clinical narrative: patient received 2 doses of varicella vaccine, the Proquad and Varivax.
Age: 37.0
Sex: F
Vaccine: RAB
Symptoms: Bacterial test negative, Diarrhoea, Parasite stool test negative
Clinical narrative: 8/1/2024: Rabies #2 around 10:30am: diarrhea started around 1pm. Severe watery diarrhea. 4-6x/day. Nonbloody. No mucous. No fever.  Diarrhea persisted and was was seen at an urgent care 8/6/2024. Rectal swab for PCR stool culture obtained. Symptomatic tx w/ Rx carafate, ondansetron prn but denies nausea. Carafate helps temporarily. Drinking well w/o issue. Results pending. No ab pain or nausea. Otherwise well. no sick contacts.
Age: 3.0
Sex: M
Vaccine: DTAP, HEP, HEPA, HIBV, PNC20, VARCEL
Symptoms: Erythema
Clinical narrative: Patient presented with redness around eyes. Denie SOB, itching or any other symptoms
Age: 5.0
Sex: M
Vaccine: DTAPIPV, MMRV
Symptoms: Head injury, Syncope
Clinical narrative: Syncopal episode from standing position 10 minutes post immunization. Hit posterior head off floor.
Age: 12.0
Sex: F
Vaccine: COVID19-2
Symptoms: No adverse event, Underdose
Clinical narrative: UNDERDOSED, PT WAS 12YEARS AND 10 MONTHS AT TIME OF VACCINATION, BUT WAS GIVEN 0.25ML. NO ADR TO OUR KNOWLEDGE
Age: 71.0
Sex: F
Vaccine: VARZOS
Symptoms: Mobility decreased, Pain in extremity
Clinical narrative: patient is stating that since she received her second dose of Shingrix, she can not lift her arm normally and it is very sore.
Age: 16.0
Sex: F
Vaccine: MENB
Symptoms: Feeling abnormal, Injection site pain, Oropharyngeal pain, Pain, Urticaria
Clinical narrative: PARENTS FATHER CALLED US ON 8-13-24 AND STATES PATIENT STARTED TO FEEL BAD ON 8-9-24 WITH SYMPTOMS OF NAUSEA, ABDOMINAL CRAMPS, INJECTION SITE PAIN RADIATING TO HER FINGERS ON LEFT SIDE AND STATES SHE DEVELOPED HIVES AND A SORETHROAT ON 8-12-24. STATES THE PATIENT IS STARTING TO FEEL BETTER NOW ON 8-13-24.
Age: 38.0
Sex: F
Vaccine: HPV9, HPV9, HPV9
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Patient was given the vaccine too early.
Age: 38.0
Sex: F
Vaccine: HPV9, HPV9, HPV9
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: Patient was given the vaccine too early.
Age: 4.0
Sex: M
Vaccine: DTAPIPV, MMRV
Symptoms: Inappropriate schedule of product administration
Clinical narrative: First dose of kinrix brand, but has had 4 dtaps and 3 polio prior. This was the first dose of proquad, but has had MMR and Varicella separately in the past.
Age: 72.0
Sex: F
Vaccine: HEP
Symptoms: Incorrect dose administered, Pain in extremity
Clinical narrative: No direct adverse events were reported. Patient received the wrong dose of vaccine at the time of administration. Patient report no side effects or adverse events aside from a typical sore arm.
Age: 46.0
Sex: F
Vaccine: PNC15
Symptoms: Cellulitis, Erythema, Hypersensitivity, Pain in extremity, Rash
Clinical narrative: Chief Complaint: ALLERGIC REACTION   Patient is a 46 y.o. female who presents to the clinic today for vaccination site reaction. Patient had her Pneumococcal Conjugate Vaccine 15-Valent vaccination on 7/29/24. Today she states that the redness over her arm has spread and is now painful and warm to the touch. She has never had a reaction like this to a vaccination before. Patient denies any recent fevers, chest pain, shortness of breath, abdominal pain, dizziness or syncope. All questions were encouraged and answered to patient's satisfaction.  The history is provided by the patient.  Review of Systems  Constitutional:  Negative for fever.  HENT:  Negative for congestion and sore throat.   Eyes:  Negative for blurred vision.  Respiratory:  Negative for cough and shortness of breath.   Cardiovascular:  Negative for chest pain and palpitations.  Gastrointestinal:  Negative for abdominal pain, diarrhea, nausea and vomiting.  Genitourinary:  Negative for dysuria.  Musculoskeletal:  Negative for back pain and myalgias.  Skin:  Positive for rash.  Neurological:  Negative for dizziness and weakness.  ASSESSMENT AND PLAN:  1. Cellulitis of left upper extremity (Primary) -     Cephalexin; Take 2 capsules by mouth 3 (three) times daily for 5 days. Indications: Cellulitis  Dispense: 30 capsule; Refill: 0 -used antibiotics stewardship and reviewed antibiotics dose with ambulatory pharmacist.  -recommend complete entire antibiotics course -following having vaccination in arm, will review with vaccination champion of our clinical office.  -Recommend following up if symptoms persist, worsen or change.
Age: 46.0
Sex: F
Vaccine: PNC15
Symptoms: Skin warm
Clinical narrative: Chief Complaint: ALLERGIC REACTION   Patient is a 46 y.o. female who presents to the clinic today for vaccination site reaction. Patient had her Pneumococcal Conjugate Vaccine 15-Valent vaccination on 7/29/24. Today she states that the redness over her arm has spread and is now painful and warm to the touch. She has never had a reaction like this to a vaccination before. Patient denies any recent fevers, chest pain, shortness of breath, abdominal pain, dizziness or syncope. All questions were encouraged and answered to patient's satisfaction.  The history is provided by the patient.  Review of Systems  Constitutional:  Negative for fever.  HENT:  Negative for congestion and sore throat.   Eyes:  Negative for blurred vision.  Respiratory:  Negative for cough and shortness of breath.   Cardiovascular:  Negative for chest pain and palpitations.  Gastrointestinal:  Negative for abdominal pain, diarrhea, nausea and vomiting.  Genitourinary:  Negative for dysuria.  Musculoskeletal:  Negative for back pain and myalgias.  Skin:  Positive for rash.  Neurological:  Negative for dizziness and weakness.  ASSESSMENT AND PLAN:  1. Cellulitis of left upper extremity (Primary) -     Cephalexin; Take 2 capsules by mouth 3 (three) times daily for 5 days. Indications: Cellulitis  Dispense: 30 capsule; Refill: 0 -used antibiotics stewardship and reviewed antibiotics dose with ambulatory pharmacist.  -recommend complete entire antibiotics course -following having vaccination in arm, will review with vaccination champion of our clinical office.  -Recommend following up if symptoms persist, worsen or change.
Age: 67.0
Sex: F
Vaccine: VARZOS
Symptoms: Decreased appetite, Dyspnoea, Headache, Lethargy, Malaise
Clinical narrative: On 8/13/24 patient returned to pharmacy counter stating " I had a severe reaction to the Shingrix vaccine you gave me on 7/26/24." Patient reports the following: severe headache, loss of appetite, lethargic, difficultly breathing. Patient states she has been bed ridden for past 19 days and today was first day she felt like getting out of bed. She never had a fever. She treated her difficulty breathing with Albuterol and Zyrtec. She did not report this to her MD. She  still reports not feeling well. I immediately called her MD and spoke with RN. RN will relay message to Dr. and they will contact patient.
Age: 67.0
Sex: F
Vaccine: VARZOS
Symptoms: Mobility decreased
Clinical narrative: On 8/13/24 patient returned to pharmacy counter stating " I had a severe reaction to the Shingrix vaccine you gave me on 7/26/24." Patient reports the following: severe headache, loss of appetite, lethargic, difficultly breathing. Patient states she has been bed ridden for past 19 days and today was first day she felt like getting out of bed. She never had a fever. She treated her difficulty breathing with Albuterol and Zyrtec. She did not report this to her MD. She  still reports not feeling well. I immediately called her MD and spoke with RN. RN will relay message to Dr. and they will contact patient.
Age: 3.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: MA dministered an expired vaccine to the patient. The vaccine was pulled and MA was reminded to double check the expiration dates on all vaccines when given them. Patient did not have an adverse reactions.
Age: 14.0
Sex: M
Vaccine: VARCEL
Symptoms: Rash maculo-papular
Clinical narrative: He started to develop a maculopapular rash about one week after receiving the vaccine.
Age: 64.0
Sex: F
Vaccine: PNC20
Symptoms: Swelling face, Swollen tongue
Clinical narrative: Swelling in the tongue and the face.
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Magnetic resonance imaging abnormal, Mobility decreased, Neuralgia, Osteoarthritis, Pain in extremity
Clinical narrative: On May 16, 2021 I wouke up at approximately 2:00 am with excrutiating arm pain in my left arm and I could not move it.  I had my duyghter take me to the Emergency Room.  As I had not injured or done anythin unusual with my the doctor took an x-ray and gave me nerve and pain medication, and told me to follow up with my primary car doctor.  Dr. ordered an MRI.  On June 1, 2021 I had the MRI done.  The results were rotator cuff tendinopathy and join osteoarthritis.  I was then referred to physical therapy.
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Tendon disorder, X-ray
Clinical narrative: On May 16, 2021 I wouke up at approximately 2:00 am with excrutiating arm pain in my left arm and I could not move it.  I had my duyghter take me to the Emergency Room.  As I had not injured or done anythin unusual with my the doctor took an x-ray and gave me nerve and pain medication, and told me to follow up with my primary car doctor.  Dr. ordered an MRI.  On June 1, 2021 I had the MRI done.  The results were rotator cuff tendinopathy and join osteoarthritis.  I was then referred to physical therapy.
Age: 72.0
Sex: F
Vaccine: RSV
Symptoms: Audiogram, Balance disorder, Blood test, Dizziness, Magnetic resonance imaging
Clinical narrative: Weakness in upper thighs. Off balance  feeling in head. Off kilter when moving. Ongoing since vaccination.
Age: 72.0
Sex: F
Vaccine: RSV
Symptoms: Muscular weakness
Clinical narrative: Weakness in upper thighs. Off balance  feeling in head. Off kilter when moving. Ongoing since vaccination.
Age: 1.0
Sex: M
Vaccine: HEPA, MMR, VARCEL
Symptoms: Blister, Dyspnoea, Swelling face
Clinical narrative: FIRST DAY ONE BLISTER ON HIS CHEEK. DAY 2 FACIAL SWELLING AND BLISTERS ON ALL OF HIS BODY. DAY 3 DAY STILL SWOLLEN AND BLISTERS, TROUBLE BREATHING. PT WAS TAKEN TO THE ER WHERE THEY ADMINISTERED BENADRYL, STEROID INJECTION. PO STEROIDS FOR A WEEK.
Age: 45.0
Sex: M
Vaccine: COVID19, HEP, MMR, UNK, MMR
Symptoms: Blood glucose normal, Dizziness, Injection site pruritus, Loss of consciousness, Nausea
Clinical narrative: Patient complained to wife after staff left room approximately 5 minutes after his 4th vaccine was given that he had itchiness to the MMR site on his left forearm, soon after began feeling cold feet and hands, lightheaded. Wife witnessed patient become unconscious and called for staff. On arrival  staff found patient in chair, breathing but not responsive. Patient was moved to the floor by staff, legs elevated, vitals taken, blood sugar checked and EMS notified. Vitals were within normal limits and blood sugar was 118. Patient began conscious approximately 2-3 minutes after placed on floor. Alert, able to talk and respond to questions. Patient stated he had not had breakfast this morning and in the past he had fainted similar situations. Patient was kept on the floor but given juice, water, a breakfast bar. After approximately 10 minutes patient was able to sit up. Vitals recheck and within normal limits. Patient complained of nausea and feeling cold in extremeties and returned to laying down on floor. Patient remained there for another 10-15 min approximately and then returned to a sitting position to which he tolerated at this time. He was able to ambulate out of clinic independently.
Age: 45.0
Sex: M
Vaccine: COVID19, HEP, MMR, UNK, MMR
Symptoms: Peripheral coldness, Syncope, Unresponsive to stimuli
Clinical narrative: Patient complained to wife after staff left room approximately 5 minutes after his 4th vaccine was given that he had itchiness to the MMR site on his left forearm, soon after began feeling cold feet and hands, lightheaded. Wife witnessed patient become unconscious and called for staff. On arrival  staff found patient in chair, breathing but not responsive. Patient was moved to the floor by staff, legs elevated, vitals taken, blood sugar checked and EMS notified. Vitals were within normal limits and blood sugar was 118. Patient began conscious approximately 2-3 minutes after placed on floor. Alert, able to talk and respond to questions. Patient stated he had not had breakfast this morning and in the past he had fainted similar situations. Patient was kept on the floor but given juice, water, a breakfast bar. After approximately 10 minutes patient was able to sit up. Vitals recheck and within normal limits. Patient complained of nausea and feeling cold in extremeties and returned to laying down on floor. Patient remained there for another 10-15 min approximately and then returned to a sitting position to which he tolerated at this time. He was able to ambulate out of clinic independently.
Age: 45.0
Sex: M
Vaccine: COVID19, HEP, MMR, UNK, MMR
Symptoms: Incorrect route of product administration, Syncope
Clinical narrative: Patient complained to wife after staff left room approximately 5 minutes after his 4th vaccine was given that he had itchiness to the MMR site on his left forearm, soon after began feeling cold feet and hands, lightheaded. Wife witnessed patient become unconscious and called for staff. On arrival  staff found patient in chair, breathing but not responsive. Patient was moved to the floor by staff, legs elevated, vitals taken, blood sugar checked and EMS notified. Vitals were within normal limits and blood sugar was 118. Patient began conscious approximately 2-3 minutes after placed on floor. Alert, able to talk and respond to questions. Patient stated he had not had breakfast this morning and in the past he had fainted similar situations. Patient was kept on the floor but given juice, water, a breakfast bar. After approximately 10 minutes patient was able to sit up. Vitals recheck and within normal limits. Patient complained of nausea and feeling cold in extremeties and returned to laying down on floor. Patient remained there for another 10-15 min approximately and then returned to a sitting position to which he tolerated at this time. He was able to ambulate out of clinic independently.
Age: 6.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Acute respiratory failure, Bacterial test positive, COVID-19, Culture urine positive, Cystitis
Clinical narrative: Primary Care Physician at Discharge: MD  Admission Date: 5/10/2024 Discharge Date: 5/15/2023 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute cystitis without hematuria [N30.00] Acute hypoxic respiratory failure  [J96.01] COVID-19 virus infection [U07.1] Sepsis [A41.9]   HOSPITAL COURSE: Presentation: Patient is a 8 y.o. 3 m.o. female history notable for Schaff-Yang syndrome, which involves a seizure disorder, global developmental delay, gastrostomy tube dependence, protein calorie malnutrition, recurrent pneumonia and UTI. She presented with 1 day history of fever and increase in "vaginal discharge". Brought to ED for further evaluation where she was found to be febrile and tachycardic. Work up significant for COVID-19 positive on respiratory panel and urinalysis showing large leukocyte esterase and moderate bacteria. She was given 20ml/kg NS bolus, x1 dose of bactrim. Transferred to unit for further management given respiratory distress.   Hospital Course by System:    Respiratory/ENT:   Initially placed on BIPAP 12/7 on admission. Started on respiratory treatments (albuterol, hypertonic saline) and glycopyrrolate to help with secretions. Home medications were also resumed. Respiratory distress improved gradually. She required BIPAP intermittently during this hospitalization to help with respiratory distress. She was transitioned to home respiratory support, 0.5L via NC during the day and home CPAP 7 and 1LPM settings at night.   Cardiovascular:  No acute events.   Renal/Genitourinary:  Daily monitoring of electrolytes which remained stable.   FEN/GI:   Initially kept NPO but feeds were resumed once respiratory distress resolved. Patient tolerated feeds according to home regimen x7 feeds per day.   Hematologic: no acute concerns.   Infectious Disease:  Completed 5 day course of remdesivir. Urine culture was positive for klebsiella oxytoca, so she was started on bactrim based on susceptibilities and completed 3 day course. She also received decadron for 3 days for COVID-19 infection.   Neurologic/Pain/Sedation:  Briefly on precedex drip while on BiPAP. Home Keppra continued. No seizure like activity during this admission.
Age: 6.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Increased bronchial secretion, Klebsiella test positive, Nothing by mouth order, Positive airway pressure therapy, Pyrexia
Clinical narrative: Primary Care Physician at Discharge: MD  Admission Date: 5/10/2024 Discharge Date: 5/15/2023 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute cystitis without hematuria [N30.00] Acute hypoxic respiratory failure  [J96.01] COVID-19 virus infection [U07.1] Sepsis [A41.9]   HOSPITAL COURSE: Presentation: Patient is a 8 y.o. 3 m.o. female history notable for Schaff-Yang syndrome, which involves a seizure disorder, global developmental delay, gastrostomy tube dependence, protein calorie malnutrition, recurrent pneumonia and UTI. She presented with 1 day history of fever and increase in "vaginal discharge". Brought to ED for further evaluation where she was found to be febrile and tachycardic. Work up significant for COVID-19 positive on respiratory panel and urinalysis showing large leukocyte esterase and moderate bacteria. She was given 20ml/kg NS bolus, x1 dose of bactrim. Transferred to unit for further management given respiratory distress.   Hospital Course by System:    Respiratory/ENT:   Initially placed on BIPAP 12/7 on admission. Started on respiratory treatments (albuterol, hypertonic saline) and glycopyrrolate to help with secretions. Home medications were also resumed. Respiratory distress improved gradually. She required BIPAP intermittently during this hospitalization to help with respiratory distress. She was transitioned to home respiratory support, 0.5L via NC during the day and home CPAP 7 and 1LPM settings at night.   Cardiovascular:  No acute events.   Renal/Genitourinary:  Daily monitoring of electrolytes which remained stable.   FEN/GI:   Initially kept NPO but feeds were resumed once respiratory distress resolved. Patient tolerated feeds according to home regimen x7 feeds per day.   Hematologic: no acute concerns.   Infectious Disease:  Completed 5 day course of remdesivir. Urine culture was positive for klebsiella oxytoca, so she was started on bactrim based on susceptibilities and completed 3 day course. She also received decadron for 3 days for COVID-19 infection.   Neurologic/Pain/Sedation:  Briefly on precedex drip while on BiPAP. Home Keppra continued. No seizure like activity during this admission.
Age: 6.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Respiratory distress, Respiratory pathogen panel, SARS-CoV-2 test positive, Sepsis, Tachycardia
Clinical narrative: Primary Care Physician at Discharge: MD  Admission Date: 5/10/2024 Discharge Date: 5/15/2023 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute cystitis without hematuria [N30.00] Acute hypoxic respiratory failure  [J96.01] COVID-19 virus infection [U07.1] Sepsis [A41.9]   HOSPITAL COURSE: Presentation: Patient is a 8 y.o. 3 m.o. female history notable for Schaff-Yang syndrome, which involves a seizure disorder, global developmental delay, gastrostomy tube dependence, protein calorie malnutrition, recurrent pneumonia and UTI. She presented with 1 day history of fever and increase in "vaginal discharge". Brought to ED for further evaluation where she was found to be febrile and tachycardic. Work up significant for COVID-19 positive on respiratory panel and urinalysis showing large leukocyte esterase and moderate bacteria. She was given 20ml/kg NS bolus, x1 dose of bactrim. Transferred to unit for further management given respiratory distress.   Hospital Course by System:    Respiratory/ENT:   Initially placed on BIPAP 12/7 on admission. Started on respiratory treatments (albuterol, hypertonic saline) and glycopyrrolate to help with secretions. Home medications were also resumed. Respiratory distress improved gradually. She required BIPAP intermittently during this hospitalization to help with respiratory distress. She was transitioned to home respiratory support, 0.5L via NC during the day and home CPAP 7 and 1LPM settings at night.   Cardiovascular:  No acute events.   Renal/Genitourinary:  Daily monitoring of electrolytes which remained stable.   FEN/GI:   Initially kept NPO but feeds were resumed once respiratory distress resolved. Patient tolerated feeds according to home regimen x7 feeds per day.   Hematologic: no acute concerns.   Infectious Disease:  Completed 5 day course of remdesivir. Urine culture was positive for klebsiella oxytoca, so she was started on bactrim based on susceptibilities and completed 3 day course. She also received decadron for 3 days for COVID-19 infection.   Neurologic/Pain/Sedation:  Briefly on precedex drip while on BiPAP. Home Keppra continued. No seizure like activity during this admission.
Age: 6.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Urine electrolytes, Vaginal discharge, White blood cells urine positive
Clinical narrative: Primary Care Physician at Discharge: MD  Admission Date: 5/10/2024 Discharge Date: 5/15/2023 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute cystitis without hematuria [N30.00] Acute hypoxic respiratory failure  [J96.01] COVID-19 virus infection [U07.1] Sepsis [A41.9]   HOSPITAL COURSE: Presentation: Patient is a 8 y.o. 3 m.o. female history notable for Schaff-Yang syndrome, which involves a seizure disorder, global developmental delay, gastrostomy tube dependence, protein calorie malnutrition, recurrent pneumonia and UTI. She presented with 1 day history of fever and increase in "vaginal discharge". Brought to ED for further evaluation where she was found to be febrile and tachycardic. Work up significant for COVID-19 positive on respiratory panel and urinalysis showing large leukocyte esterase and moderate bacteria. She was given 20ml/kg NS bolus, x1 dose of bactrim. Transferred to unit for further management given respiratory distress.   Hospital Course by System:    Respiratory/ENT:   Initially placed on BIPAP 12/7 on admission. Started on respiratory treatments (albuterol, hypertonic saline) and glycopyrrolate to help with secretions. Home medications were also resumed. Respiratory distress improved gradually. She required BIPAP intermittently during this hospitalization to help with respiratory distress. She was transitioned to home respiratory support, 0.5L via NC during the day and home CPAP 7 and 1LPM settings at night.   Cardiovascular:  No acute events.   Renal/Genitourinary:  Daily monitoring of electrolytes which remained stable.   FEN/GI:   Initially kept NPO but feeds were resumed once respiratory distress resolved. Patient tolerated feeds according to home regimen x7 feeds per day.   Hematologic: no acute concerns.   Infectious Disease:  Completed 5 day course of remdesivir. Urine culture was positive for klebsiella oxytoca, so she was started on bactrim based on susceptibilities and completed 3 day course. She also received decadron for 3 days for COVID-19 infection.   Neurologic/Pain/Sedation:  Briefly on precedex drip while on BiPAP. Home Keppra continued. No seizure like activity during this admission.
Age: 88.0
Sex: F
Vaccine: TDAP
Symptoms: Injection site erythema, Skin warm
Clinical narrative: redness around injection site, warm to the touch
Age: 1.75
Sex: M
Vaccine: COVID19
Symptoms: Abdominal X-ray, Anion gap, Blood bicarbonate decreased, Blood glucose decreased, COVID-19
Clinical narrative: Discharge Provider: MD  Primary Care Physician at Discharge: DO Admission Date: 8/10/2024  Discharge Date: 8/11/2024 DETAILS OF HOSPITAL STAY: Ketotic hypoglycemia [E16.1] Decreased oral intake [R63.8] Dehydration in pediatric patient [E86.0] Hypoglycemia [E16.2] Dehydration [E86.0]   HOSPITAL COURSE: Pateint is a 3 y.o. male with PMHx asthma, GERD, and ASD who was admitted on 8/10/2024 for dehydration in the setting of COVID-19 infection. In the ED found to have low glucose to 40, given Dextrose 25% to replete and responded well with repeat point of care glucose was 128. UA showing elevated glucose and ketones likely 2/2 the D25 bolus.  He subsequently received a 20 mL/kilos of saline bolus which he responded well to.  CMP remarkable for anion gap of 22 and bicarb of 16 likely due to dehydration. CBC unremarkable.  Upper GI study with small bowel follow-through with fluoroscopy was negative.  US for intussusception negative. Abdominal xray notable for constipation, miralax given with successful emptying.  During admission received mIVF and supportive care for COVID-19.  On day of discharge, PO challenged with success. Patient discharged in hemodynamically stable condition with mom as well as zofran for nausea and to encourage fluid intake.  Signs and symptoms of when to return were discussed with mom and questions answered at bedside.
Age: 1.75
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Constipation, Dehydration, Full blood count normal, Glucose urine present
Clinical narrative: Discharge Provider: MD  Primary Care Physician at Discharge: DO Admission Date: 8/10/2024  Discharge Date: 8/11/2024 DETAILS OF HOSPITAL STAY: Ketotic hypoglycemia [E16.1] Decreased oral intake [R63.8] Dehydration in pediatric patient [E86.0] Hypoglycemia [E16.2] Dehydration [E86.0]   HOSPITAL COURSE: Pateint is a 3 y.o. male with PMHx asthma, GERD, and ASD who was admitted on 8/10/2024 for dehydration in the setting of COVID-19 infection. In the ED found to have low glucose to 40, given Dextrose 25% to replete and responded well with repeat point of care glucose was 128. UA showing elevated glucose and ketones likely 2/2 the D25 bolus.  He subsequently received a 20 mL/kilos of saline bolus which he responded well to.  CMP remarkable for anion gap of 22 and bicarb of 16 likely due to dehydration. CBC unremarkable.  Upper GI study with small bowel follow-through with fluoroscopy was negative.  US for intussusception negative. Abdominal xray notable for constipation, miralax given with successful emptying.  During admission received mIVF and supportive care for COVID-19.  On day of discharge, PO challenged with success. Patient discharged in hemodynamically stable condition with mom as well as zofran for nausea and to encourage fluid intake.  Signs and symptoms of when to return were discussed with mom and questions answered at bedside.
Age: 1.75
Sex: M
Vaccine: COVID19
Symptoms: Hypoglycaemia, Hypophagia, Nausea, Ultrasound abdomen normal, Urine ketone body present
Clinical narrative: Discharge Provider: MD  Primary Care Physician at Discharge: DO Admission Date: 8/10/2024  Discharge Date: 8/11/2024 DETAILS OF HOSPITAL STAY: Ketotic hypoglycemia [E16.1] Decreased oral intake [R63.8] Dehydration in pediatric patient [E86.0] Hypoglycemia [E16.2] Dehydration [E86.0]   HOSPITAL COURSE: Pateint is a 3 y.o. male with PMHx asthma, GERD, and ASD who was admitted on 8/10/2024 for dehydration in the setting of COVID-19 infection. In the ED found to have low glucose to 40, given Dextrose 25% to replete and responded well with repeat point of care glucose was 128. UA showing elevated glucose and ketones likely 2/2 the D25 bolus.  He subsequently received a 20 mL/kilos of saline bolus which he responded well to.  CMP remarkable for anion gap of 22 and bicarb of 16 likely due to dehydration. CBC unremarkable.  Upper GI study with small bowel follow-through with fluoroscopy was negative.  US for intussusception negative. Abdominal xray notable for constipation, miralax given with successful emptying.  During admission received mIVF and supportive care for COVID-19.  On day of discharge, PO challenged with success. Patient discharged in hemodynamically stable condition with mom as well as zofran for nausea and to encourage fluid intake.  Signs and symptoms of when to return were discussed with mom and questions answered at bedside.
Age: 1.75
Sex: M
Vaccine: COVID19
Symptoms: X-ray, X-ray gastrointestinal tract normal
Clinical narrative: Discharge Provider: MD  Primary Care Physician at Discharge: DO Admission Date: 8/10/2024  Discharge Date: 8/11/2024 DETAILS OF HOSPITAL STAY: Ketotic hypoglycemia [E16.1] Decreased oral intake [R63.8] Dehydration in pediatric patient [E86.0] Hypoglycemia [E16.2] Dehydration [E86.0]   HOSPITAL COURSE: Pateint is a 3 y.o. male with PMHx asthma, GERD, and ASD who was admitted on 8/10/2024 for dehydration in the setting of COVID-19 infection. In the ED found to have low glucose to 40, given Dextrose 25% to replete and responded well with repeat point of care glucose was 128. UA showing elevated glucose and ketones likely 2/2 the D25 bolus.  He subsequently received a 20 mL/kilos of saline bolus which he responded well to.  CMP remarkable for anion gap of 22 and bicarb of 16 likely due to dehydration. CBC unremarkable.  Upper GI study with small bowel follow-through with fluoroscopy was negative.  US for intussusception negative. Abdominal xray notable for constipation, miralax given with successful emptying.  During admission received mIVF and supportive care for COVID-19.  On day of discharge, PO challenged with success. Patient discharged in hemodynamically stable condition with mom as well as zofran for nausea and to encourage fluid intake.  Signs and symptoms of when to return were discussed with mom and questions answered at bedside.
Age: 58.0
Sex: F
Vaccine: FLUR4, HEPAB, VARZOS
Symptoms: Rash
Clinical narrative: Pt says she developed a rash on her neck, chest and thighs a the next day or the day after that.  She told us of the rash today 8/13/24 and says it is looking like it is going away.  Did see the rash on her neck and was a rash but looks like it is fading- going  away.
Age: 20.0
Sex: F
Vaccine: HEP
Symptoms: Product administered to patient of inappropriate age, Underdose
Clinical narrative: PEDIATRIC VACCINE WAS ADMINISTERED TO AN ADULT
Age: 16.0
Sex: M
Vaccine: MNQ
Symptoms: Chest pain, Dyspnoea
Clinical narrative: Reported by mother on 08/13/2024 approx. 2:00pm.  Hx: Patient had previously received MenQuadfi Meningococcal vaccine on 08/05/2019 with no reaction.  Mother reports her son, Patient, texted her at 12:31pm reporting dyspnea & chest pain.  School nurse recorded heart rate of 40 (x3).  Pt. w/o hx of Bradycardia.  Has a hx of anxiety and mother reports he was anxious about this immunization the night before.  Mother reports Patient had no food prior to immunization.  Vitals recorded yesterday were BP 122/64, HR 40 / 43, O2 99%, T98.2, no respiratory rate reported.  Patient was taken to Dr. (noted above) and released.  Reported vitals today are BP 116/64, O2 99-100%, HR 55.  Mother states her son is athletic. Father was present at time of immunization on 08/12/24.  Mother states physician ordered Holter monitor and an echocardiogram but the appointment for the study is approximately one month away.  Screening checklist for contraindications to vaccines for children / teens was negative for any contraindications or known history.